COMBINATION THERAPY OF VEDOLIZUMAB AND A TNF ANTAGONIST IN IBD PATIENTS WITH SEVERE CHRONIC ACTIVE, THERAPY REFRACTORY DISEASE COURSE

被引：1
|
作者：
Kuehbacher, Tanja
AbuHashem, Raed
Langel, Natalie
Schreiber, Stefan
Drvarov, Oliver
机构：
来源：
GASTROENTEROLOGY | 2017年 / 152卷 / 05期
关键词：
D O I：
10.1016/S0016-5085(17)31568-8
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Sa1933
引用
收藏
页码：S398 / S398
页数：1
相关论文
共 50 条
  • [21] COMBINATION USTEKINUMAB AND VEDOLIZUMAB THERAPY FOR REFRACTORY INFLAMMATORY BOWEL DISEASE: A SINGLE INSTITUTION CASE SERIES
    Dawoud, Nabila
    Roy, Lucas
    Elmoursi, Ahmed
    Elkammar, Mahmoud
    Eltaher, Mohamed
    Barrett, Terrence
    Perry, Courtney
    INFLAMMATORY BOWEL DISEASES, 2022, 28 : S103 - S104
  • [22] Infliximab therapy in patients with severe active refractory pyoderma gangrenosum
    Andersen, TH
    Moerk, NJ
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2004, 50 (03) : P10 - P10
  • [23] OUTCOMES OF PREGNANCY IN IBD PATIETNS TREATED WITH VEDOLIZUMAB, ANTI-TNF OR CONVENTIONAL THERAPY
    Moens, Annick
    Van der Woude, Christien Janneke
    Julsgaard, Mette
    Sebastian, Shaji
    Arebi, Naila
    Alzinaty, Mohannad
    Humblet, Evelien
    Kok, Klaartje
    Sheridan, Juliette
    Gilletta, Cyrielle
    Nancey, Stephane
    Rahier, Jean-Francois
    Bossuyt, Peter
    Cremer, Anneline
    Dewit, Sophie
    Eriksson, Carl
    Hoentjen, Frank
    Krause, Thomas
    Louis, Edouard
    Macken, Elisabeth
    Milenkovic, Zoran
    Nijs, Jochen
    Posen, Annelies
    Van Hootegem, Anneleen
    Van Moerkercke, Wouter
    Vermeire, Severine
    Shitrit, Ariella Bar-Gil
    Ferrante, Marc
    GASTROENTEROLOGY, 2019, 156 (06) : S633 - S633
  • [24] OUTCOMES AND ECONOMIC IMPACT OF SWITCHING FROM ANTI-TNF TO ANTI-TNF THERAPY COMPARED WITH SWITCHING FROM ANTI-TNF TO VEDOLIZUMAB THERAPY IN PATIENTS WITH IBD
    Chiorean, Michael V.
    Afzali, Anita
    Zhou, Zhou
    Macaulay, Dendy
    Rizzo, Joanne
    Skup, Martha
    Wang, Anthony
    GASTROENTEROLOGY, 2017, 152 (05) : S591 - S591
  • [25] Vedolizumab Therapy in Severe Pediatric Inflammatory Bowel Disease
    Conrad, Maire A.
    Stein, Ronen E.
    Maxwell, Elizabeth C.
    Albenberg, Lindsey
    Baldassano, Robert N.
    Dawany, Noor
    Grossman, Andrew B.
    Mamula, Petar
    Piccoli, David A.
    Kelsen, Judith R.
    INFLAMMATORY BOWEL DISEASES, 2016, 22 (10) : 2425 - 2431
  • [26] Long-term Combination Therapy with Anti-TNF plus Vedolizumab Induces and Maintains Remission in Therapy-refractory Ulcerative Colitis
    Fischer, Sarah
    Rath, Timo
    Geppert, Carol-Immanuel
    Manger, Bernhard
    Schett, Georg
    Neurath, Markus F.
    Atreya, Raja
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 (10): : 1621 - 1623
  • [27] Faecal calprotectin is correlated to endoscopic disease activity at Week 16 in IBD patients on vedolizumab therapy
    Pauwels, R. W. M.
    De Vries, A. C.
    Van der Woude, C. J.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S324 - S324
  • [28] Efficacy and Safety of Induction Therapy With Calcineurin Inhibitors in Combination With Vedolizumab in Patients With Refractory Ulcerative Colitis
    Pellet, Gauthier
    Stefanescu, Carmen
    Carbonnel, Franck
    Peyrin-Biroulet, Laurent
    Roblin, Xavier
    Allimant, Christophe
    Nachury, Maria
    Nancey, Stephane
    Filippi, Jerome
    Altwegg, Romain
    Brixi, Hedia
    Fotsing, Ginette
    de Rosamel, Laure
    Shili, Sarah
    Laharie, David
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2019, 17 (03) : 494 - 501
  • [29] Effect of Overweight and Obesity on the Response to Anti-TNF Therapy and Disease Course in Children With IBD
    Sila, Sara
    Aloi, Marina
    Cucinotta, Ugo
    Gianolio, Laura
    Granot, Maya
    Hradsky, Ondrej
    Hussey, Seamus
    Kang, Ben
    Karoliny, Anna
    Kolho, Kaija-Leena
    de Laffolie, Jan
    Lega, Sara
    Matar, Manar
    Norsa, Lorenzo
    Omiwole, Sharon
    Orlanski-Meyer, Esther
    Palomino, Laura
    Rohani, Pejman
    Scarallo, Luca
    Sladek, Margaret
    Sohouli, Mohammad Hassan
    Urlep, Darja
    Yerushalmy-Feler, Anat
    Zifman, Eyal
    Hojsak, Iva
    INFLAMMATORY BOWEL DISEASES, 2024,
  • [30] Comparative Effectiveness of Anti-TNF Therapy and Vedolizumab in Crohn's Disease Patients
    Chen, Nai-Yu
    Chiu, Yung-Ting
    Chuang, Chiao-Hsiung
    Chang, Yu-Ching
    Cheng, Ching-Lan
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 : 356 - 356
12345